CDR Companies

CDR Companies, founded in 1938, has evolved from an engineering firm to a multi-faceted company offering engineering consulting services, emergency management solutions, health and medical services, financial solutions, and labs. Its impressive portfolio includes overseeing over $2 billion in construction, $10 billion in disaster recovery, and $500 million in COVID-19 related medical services. CDR's team of health and medical professionals is renowned for rethinking the delivery of quality medical care, with multiple state contracts and a track record of managing over 7 million COVID-19 monoclonal antibody treatments, vaccinations, and tests. The company has established itself as a leader in the industry, with a focus on financial services, health care, and the industrial sector, and is known for its quick response time and high-quality work. Additionally, CDR offers a range of services including monoclonal antibody treatment, vaccination, and testing data management, community monoclonal antibody treatment, vaccination, and testing sites, as well as comprehensive medical services for confinement facilities. Overall, CDR Companies demonstrates a strong track record of success and an ability to adapt to the evolving needs of the market, making it an attractive prospect for potential investors seeking opportunities in the healthcare, financial, and industrial sectors.